TIBOLLA, GIANPAOLO

TIBOLLA, GIANPAOLO  

Dipartimento di Scienze Farmacologiche e Biomolecolari  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population 1-feb-2009 G.D. NorataK. GarlaschelliG. TibollaS. RaselliA.L. Catapano + Article (author) -
Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis 1-gen-2013 G. TibollaG.D. NorataA.L. Catapano + Article (author) -
Dihydrotestosterone decreases tumor necrosis factor-(alpha) and lipopolysaccharide-induced inflammatory response in human endothelial cells 1-gen-2006 G.D. NorataG. TibollaA. PolettiA.L. Catapano + Article (author) -
Effect of proprotein convertase subtilisin kexin type 9 (PCSK9) on smooth muscle cell proliferation and migration 4-giu-2013 N. FerriG. TibollaA. CorsiniA.L. Catapano + Conference Object -
Expression and secretion of PCSK9 from cultured smooth muscle cells: evidence for a direct role in atherogenesis 7-set-2011 N. FerriG. TibollaA. PirilloA. CorsiniA.L. Catapano + Conference Object -
Gene silencing approaches for the management of dyslipidaemia 25-feb-2013 G.D. NorataG. TibollaA.L. Catapano Article (author) -
HDL: To Treat or Not To Treat? 1-ago-2014 G. TibollaG.D. NorataA.L. Catapano + Article (author) -
IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the Italian general population 1-gen-2015 A. DhyaniG. TibollaA. BaragettiPELLEGATTA, FABIOG.D. NorataA.L. Catapano + Article (author) -
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency 1-mag-2010 G. TibollaG.D. NorataC. MedaL. ArnaboldiP. UboldiA. CorsiniA. MaggiE. VegetoA.L. Catapano + Article (author) -
PCSK9 deficient mice are protected from neointima formation in carotid artery injury model 10-set-2013 N. FerriG. TibollaR. BaettaA. CorsiniA.L. Catapano + Conference Object -
PCSK9 inhibition for the treatment of hypercholesterolemia:pPromises and emerging challenges 1-gen-2014 G.D. NorataG. TibollaA.L. Catapano Article (author) -
PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling 23-giu-2015 G. TibollaG.D. Norata + Article (author) -
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 1-gen-2012 N. FerriG. TibollaA. PirilloA. CorsiniA.L. Catapano + Conference Object -
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 3-nov-2011 N. FerriG. TibollaA. PirilloA. CorsiniA.L. Catapano + Conference Object -
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 1-feb-2012 N. FerriG. TibollaA. PirilloA. CorsiniA.L. Catapano + Article (author) -
Proprotein convertase subtilisin kexin type 9 (PCSK9)secreted by cultured smooth muscle cells reduces macrophages LDLR levels 1-gen-2011 N. FerriG. TibollaA. PirilloA. CorsiniA.L. Catapano + Conference Object -
PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 SECRETED BY CULTURED SMOOTH MUSCLE CELLS REDUCES MACROPHAGES LOW DENSITY LIPOPROTEIN RECEPTOR LEVELS AND FACILITATES SMOOTH MUSCLE CELL MIGRATION 1-dic-2011 N. FerriG. TibollaA. PirilloA. CorsiniA.L. Catapano + Conference Object -
Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition 1-nov-2011 G. TibollaG.D. NorataR. ArtaliF. MeneghettiA.L. Catapano Article (author) -
Statins and skeletal muscles toxicity: from clinical trials to everyday practice 1-gen-2014 G.D. NorataG. TibollaA.L. Catapano Article (author) -
Targeting PCSK9 for Hypercholesterolemia 1-gen-2014 G.D. NorataG. TibollaA.L. Catapano Article (author) -